234 related articles for article (PubMed ID: 18293932)
1. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
3. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
5. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.
Torrent M; Odorizzi F; Nogués MV; Boix E
Biomacromolecules; 2010 Aug; 11(8):1983-90. PubMed ID: 20690710
[TBL] [Abstract][Full Text] [Related]
7. Topography studies on the membrane interaction mechanism of the eosinophil cationic protein.
Torrent M; Cuyás E; Carreras E; Navarro S; López O; de la Maza A; Nogués MV; Reshetnyak YK; Boix E
Biochemistry; 2007 Jan; 46(3):720-33. PubMed ID: 17223693
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of antimicrobial properties of crustinPm1 and crustinPm7 from the black tiger shrimp Penaeus monodon.
Krusong K; Poolpipat P; Supungul P; Tassanakajon A
Dev Comp Immunol; 2012 Jan; 36(1):208-15. PubMed ID: 21855569
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
Lehrer RI; Szklarek D; Barton A; Ganz T; Hamann KJ; Gleich GJ
J Immunol; 1989 Jun; 142(12):4428-34. PubMed ID: 2656865
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of surfactant protein A and D binding to lipoteichoic acid and peptidoglycan, 2 major cell wall components of gram-positive bacteria.
van de Wetering JK; van Eijk M; van Golde LM; Hartung T; van Strijp JA; Batenburg JJ
J Infect Dis; 2001 Nov; 184(9):1143-51. PubMed ID: 11598837
[TBL] [Abstract][Full Text] [Related]
11. Origins of cell selectivity of cationic steroid antibiotics.
Ding B; Yin N; Liu Y; Cardenas-Garcia J; Evanson R; Orsak T; Fan M; Turin G; Savage PB
J Am Chem Soc; 2004 Oct; 126(42):13642-8. PubMed ID: 15493921
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial action and cell agglutination by the eosinophil cationic protein are modulated by the cell wall lipopolysaccharide structure.
Pulido D; Moussaoui M; Andreu D; Nogués MV; Torrent M; Boix E
Antimicrob Agents Chemother; 2012 May; 56(5):2378-85. PubMed ID: 22330910
[TBL] [Abstract][Full Text] [Related]
13. Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides.
Epand RF; Mowery BP; Lee SE; Stahl SS; Lehrer RI; Gellman SH; Epand RM
J Mol Biol; 2008 May; 379(1):38-50. PubMed ID: 18440552
[TBL] [Abstract][Full Text] [Related]
14. Both aromatic and cationic residues contribute to the membrane-lytic and bactericidal activity of eosinophil cationic protein.
Carreras E; Boix E; Rosenberg HF; Cuchillo CM; Nogués MV
Biochemistry; 2003 Jun; 42(22):6636-44. PubMed ID: 12779318
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the eosinophil cationic protein antimicrobial activity.
Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
[TBL] [Abstract][Full Text] [Related]
16. Protein post-translational modification in host defense: the antimicrobial mechanism of action of human eosinophil cationic protein native forms.
Salazar VA; Rubin J; Moussaoui M; Pulido D; Nogués MV; Venge P; Boix E
FEBS J; 2014 Dec; 281(24):5432-46. PubMed ID: 25271100
[TBL] [Abstract][Full Text] [Related]
17. Esculentin-1b(1-18)--a membrane-active antimicrobial peptide that synergizes with antibiotics and modifies the expression level of a limited number of proteins in Escherichia coli.
Marcellini L; Borro M; Gentile G; Rinaldi AC; Stella L; Aimola P; Barra D; Mangoni ML
FEBS J; 2009 Oct; 276(19):5647-64. PubMed ID: 19725877
[TBL] [Abstract][Full Text] [Related]
18. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
[TBL] [Abstract][Full Text] [Related]
19. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
Singh A; Batra JK
Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
[TBL] [Abstract][Full Text] [Related]
20. Vitellogenin is a cidal factor capable of killing bacteria via interaction with lipopolysaccharide and lipoteichoic acid.
Li Z; Zhang S; Zhang J; Liu M; Liu Z
Mol Immunol; 2009 Oct; 46(16):3232-9. PubMed ID: 19729202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
